268 related articles for article (PubMed ID: 19264827)
1. New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring.
Fritz BE; Hauke RJ; Stickle DF
Ann Clin Biochem; 2009 May; 46(Pt 3):253-6. PubMed ID: 19264827
[TBL] [Abstract][Full Text] [Related]
2. Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.
Park S; Wians FH; Cadeddu JA
Int J Urol; 2007 Mar; 14(3):251-3. PubMed ID: 17430267
[TBL] [Abstract][Full Text] [Related]
3. Serum heterophile antibodies interfere with prostate specific antigen test and result in over treatment in a patient with prostate cancer.
Morgan BR; Tarter TH
J Urol; 2001 Dec; 166(6):2311-2. PubMed ID: 11696766
[TBL] [Abstract][Full Text] [Related]
4. Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies.
Anderson CB; Pyle AL; Woodworth A; Cookson MS; Smith JA; Barocas DA
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):182-8. PubMed ID: 22105412
[TBL] [Abstract][Full Text] [Related]
5. [False Elevation of Prostate-Specific Antigen Caused by Heterophilic Antibody Interference after Radical Prostatectomy : A Case Report].
Kamiyama Y; Somiya S; Fujikawa S; Yamada Y; Tamaki M; Kanaoka T; Hayashi T
Hinyokika Kiyo; 2017 Oct; 63(10):435-437. PubMed ID: 29103259
[TBL] [Abstract][Full Text] [Related]
6. Incorrect biochemistry complicates prostate cancer management.
McAuley I; Steinhoff G; McNeely M; Blood P
Can J Urol; 2002 Apr; 9(2):1496-7. PubMed ID: 12010595
[TBL] [Abstract][Full Text] [Related]
7. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration.
Altinier S; Varagnolo M; Zaninotto M; Boccagni P; Plebani M
Clin Chim Acta; 2009 Apr; 402(1-2):193-5. PubMed ID: 19150346
[TBL] [Abstract][Full Text] [Related]
8. Interference of heterophilic antibodies with free prostate-specific antigen in the Beckman-Coulter (Unicel DxI) assay, inverting the free/total prostate-specific antigen ratio.
Pedrosa W; Teixeira L
Ann Clin Biochem; 2009 Jul; 46(Pt 4):344-5. PubMed ID: 19454533
[No Abstract] [Full Text] [Related]
9. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
[TBL] [Abstract][Full Text] [Related]
10. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?
Godoy G; Tareen BU; Lepor H
Urology; 2009 Jul; 74(1):167-70. PubMed ID: 19406457
[TBL] [Abstract][Full Text] [Related]
11. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
12. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
13. False elevations in prostate-specific antigen levels affecting patient management.
Kummar S; Shafi NQ
Clin Adv Hematol Oncol; 2004 Sep; 2(9):599-601; discussion 602. PubMed ID: 16163243
[No Abstract] [Full Text] [Related]
14. Repeated spurious elevation of serum prostate-specific antigen values solved by chemiluminescence analysis: A possible interference by heterophilic antibodies.
Domínguez A; Bayó M; Muñoz-Rodríguez J; Bellido JA; Abascal-Junquera JM; Hannaoui N; Banús JM
Korean J Urol; 2015 Nov; 56(11):785-7. PubMed ID: 26568798
[TBL] [Abstract][Full Text] [Related]
15. Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
Loeb S; Schaeffer EM; Chan DW; Carter HB; Walsh PC; Sokoll LJ
Urology; 2009 May; 73(5):947-9. PubMed ID: 19394489
[No Abstract] [Full Text] [Related]
16. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
[TBL] [Abstract][Full Text] [Related]
17. [PSA kinetics after total prostatectomy].
Riedinger JM; Eche N; Fulla Y; Thuillier F
Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
19. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
Gray MA; Cooke RR; Weinstein P; Nacey JN
Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
[TBL] [Abstract][Full Text] [Related]
20. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions].
Quero L; Mongiat-Artus P; Ravery V; Hennequin V; Maylin C; Desgrandchamps F; Hennequin C
Cancer Radiother; 2009 Jul; 13(4):267-75. PubMed ID: 19446487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]